Among 4 analysts covering Aimmune Therapeutics (NASDAQ:AIMT), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aimmune Therapeutics had 5 analyst reports since August 31, 2015 according to SRatingsIntel. Piper Jaffray initiated Aimmune Therapeutics, Inc. (NASDAQ:AIMT) on Monday, August 31 with “Overweight” rating. On Monday, August 31 the stock rating was initiated by Credit Suisse with “Outperform”. The stock of Aimmune Therapeutics, Inc. (NASDAQ:AIMT) earned “Overweight” rating by Piper Jaffray on Tuesday, November 17. The rating was initiated by JMP Securities on Monday, September 26 with “Mkt Outperform”. The firm earned “Buy” rating on Monday, August 31 by Bank of America. See Aimmune Therapeutics, Inc. (NASDAQ:AIMT) latest ratings:
Analysts expect Hi-Crush Partners LP (NYSE:HCLP) to report $0.50 EPS on February, 20.They anticipate $0.61 EPS change or 554.55% from last quarter’s $-0.11 EPS. HCLP’s profit would be $45.51M giving it 5.85 P/E if the $0.50 EPS is correct. After having $0.32 EPS previously, Hi-Crush Partners LP’s analysts see 56.25% EPS growth. The stock decreased 4.49% or $0.55 during the last trading session, reaching $11.7. About 2.48M shares traded or 28.86% up from the average. Hi-Crush Partners LP (NYSE:HCLP) has risen 114.79% since February 8, 2017 and is uptrending. It has outperformed by 98.09% the S&P500.
Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.78, from 1.66 in 2017Q2. It is negative, as 21 investors sold Hi-Crush Partners LP shares while 30 reduced holdings. 17 funds opened positions while 28 raised stakes. 37.15 million shares or 16.45% less from 44.46 million shares in 2017Q2 were reported. Peconic Ptnrs Lc owns 67,380 shares. Group Inc One Trading Lp has 69,612 shares for 0.01% of their portfolio. Selz Cap Ltd Liability Com invested in 0.38% or 200,079 shares. New York-based Clear Harbor Asset Mngmt Lc has invested 1.5% in Hi-Crush Partners LP (NYSE:HCLP). S Muoio And Com Ltd Liability Corporation reported 20,192 shares or 0.1% of all its holdings. Blair William Com Il accumulated 80,650 shares. Atlantic Trust Group Ltd Liability has 0.02% invested in Hi-Crush Partners LP (NYSE:HCLP). Sg Americas has 0.01% invested in Hi-Crush Partners LP (NYSE:HCLP). Us Fincl Bank De invested in 0% or 1,800 shares. L & S Advisors has 134,575 shares for 0.21% of their portfolio. Malaga Cove Capital Lc reported 83,019 shares or 0.45% of all its holdings. Deprince Race And Zollo accumulated 17,000 shares or 0% of the stock. Parkwood Limited Liability Corp has invested 0.08% in Hi-Crush Partners LP (NYSE:HCLP). Tradewinds Mngmt Limited Co reported 112 shares stake. Sentinel Asset Mgmt Incorporated holds 0.01% of its portfolio in Hi-Crush Partners LP (NYSE:HCLP) for 53,679 shares.
Hi-Crush Partners LP produces, transports, markets, and distributes monocrystalline sand in the United States. The company has market cap of $1.07 billion. The monocrystalline sand is a mineral that is used as a proppant to enhance the recovery rates of hydrocarbons from oil and natural gas wells. It has a 28.4 P/E ratio. It owns, operates, and develops sand reserves, and excavation and processing facilities, which include 1,447-acre facility with integrated rail infrastructure, located near Independence, Wisconsin, and Whitehall, Wisconsin; 971-acre facility with integrated rail infrastructure, located in Wyeville, Wisconsin; the Augusta facility situated in Eau Claire County, Wisconsin; and the Blair facility.
Among 18 analysts covering Hi-Crush Partners (NYSE:HCLP), 11 have Buy rating, 3 Sell and 4 Hold. Therefore 61% are positive. Hi-Crush Partners had 54 analyst reports since July 24, 2015 according to SRatingsIntel. On Monday, September 25 the stock rating was initiated by Piper Jaffray with “Buy”. The stock has “Buy” rating by Jefferies on Wednesday, April 12. The firm has “Buy” rating by Piper Jaffray given on Tuesday, October 31. Raymond James upgraded the stock to “Strong Buy” rating in Wednesday, June 15 report. Cowen & Co maintained it with “Outperform” rating and $25 target in Friday, August 7 report. Wunderlich maintained Hi-Crush Partners LP (NYSE:HCLP) on Thursday, October 1 with “Hold” rating. The firm has “Outperform” rating given on Wednesday, October 28 by Cowen & Co. The stock of Hi-Crush Partners LP (NYSE:HCLP) has “Buy” rating given on Friday, February 26 by DA Davidson. The stock has “Outperform” rating by Robert W. Baird on Thursday, July 30. On Wednesday, September 6 the stock rating was initiated by Janney Capital with “Hold”.
The stock increased 5.08% or $1.82 during the last trading session, reaching $37.62. About 582,180 shares traded or 42.74% up from the average. Aimmune Therapeutics, Inc. (NASDAQ:AIMT) has risen 32.49% since February 8, 2017 and is uptrending. It has outperformed by 15.79% the S&P500.